NTRA
Natera, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$328.18
+0.16%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 198.91x
- P/S forward
- 15.17x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 25.97x
- Price / sales
- 17.47x
- Price / cash flow
- 207.26x
Enterprise value
- Enterprise value
- $46.5B
- EV / sales
- 17.16x
- EV / EBITDA
- -259.31x
- EV / EBIT
- -160.36x
- Market cap
- $47.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026